YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
114 hedge funds and large institutions have $1.11B invested in Y-mAbs Therapeutics in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+8
Holders Change %
+7.55%
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
16
Increased
47
Reduced
34
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$15.9M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$13.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.7M |
| 4 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$10.9M |
| 5 |
Goldman Sachs
New York
|
+$6.7M |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$13.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.32M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.29M |
| 5 |
Axa
Paris,
France
|
-$4.68M |
